Harvard Ave Acquisition Corporation is a blank check company formed to effect a merger, capital stock exchange, asset acquisition, or similar business combination with one or more operating businesses. It has no significant operations and generates no revenue while it evaluates potential acquisition targets.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 0 | — | -0 | — |
| Q3 2025 | 0 | — | -0 | — |
| Q4 2025 | 0 | — | 0.8 | — |
| Q1 2026 | 0 | — | 1.1 | — |
| Q2 2026 | 0 | — | 1.1 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Corbus Pharmaceuticals Holdings, Inc. (CRBP), Precision BioSciences, Inc. (DTIL), Paloma Acquisition Corp I (PALO), GDEV Inc. (GDEV), NovaBridge Biosciences (NBP), Pro-Dex, Inc. (PDEX)